FREE CANADA-WIDE EXPRESS SHIPPING ON ORDERS OVER $250
Reviews transferred over to Yotpo (over 140 reviews)
🍁 Owned and operated by a CF Veteran 🇨🇦
10% off: peptideparty
Special Pricing and items have moved over to Members Only (log-in required)
Pfizer bac water – In stock New Batch of G-H coming. RESTOCKED – Please double-check junk mail for emails
$120.00
In stock
Research use only; Not for human or veterinary administration. This content is not a substitute for medical advice.
VIP (vasoactive intestinal peptide) is a 28-amino-acid neuropeptide of the secretin/glucagon superfamily, studied at the VPAC1 and VPAC2 receptors. Its circulating half-life is roughly two minutes, which shapes every study design built around it. This Canadian product listing concerns laboratory research material only. It is not an authorized medicine, does not provide dosing or administration instructions, and is not intended for human or veterinary use.
VIP Canada researchers can order a 10mg vial of vasoactive intestinal peptide directly from Red Leaf Research Labs, with published analytical information, Canadian-dollar pricing and domestic express fulfilment.
For searches such as buy VIP peptide Canada, vasoactive intestinal peptide 10mg or VPAC receptor agonist, this page sets out the molecule, its receptor targets, and the one property that determines whether a given experiment with it is feasible at all.
Red Leaf Research Labs supplies research material to qualified purchasers in Canada. Nothing on this page describes a therapy, a treatment or a permitted personal use.
| Attribute | Detail |
|---|---|
| Research format | VIP 10mg, single vial |
| Physical state | Lyophilized powder |
| Analytical documentation | Third-party report available for the current lot |
| Fulfilment | Domestic Canadian express shipping |
| Intended use | Qualified laboratory research only |
Most listings for VIP mention its receptor targets and stop. The number that actually determines what you can do with it is the half-life: roughly two minutes in blood circulation.
For in-vitro work this is largely irrelevant — a receptor-binding or cell-signalling assay operates on timescales where VIP behaves normally, and VPAC1/VPAC2 pharmacology is well characterised in exactly those systems. For any whole-organism design it is decisive. A peptide cleared in minutes cannot produce a sustained systemic exposure, which is why the translational literature in this area is dominated by engineered analogues, sustained-release formulations and delivery strategies rather than by native VIP.
A laboratory planning work with this compound should settle early which of those two worlds the experiment lives in. Native VIP is an excellent receptor-pharmacology tool and a poor systemic agent, and no handling procedure changes that.
VIP was characterised as a gut peptide and named for its vasodilatory effect, but its documented roles range considerably wider than the name suggests.
In the digestive system it relaxes smooth muscle, stimulates water and electrolyte secretion into pancreatic juice and bile, and inhibits gastric acid secretion. In the cardiovascular system it produces vasodilation and coronary vasodilation and stimulates cardiac contractility. It regulates prolactin secretion and modulates growth hormone-releasing hormone activity.
The role that draws the most current research interest is circadian. VIP acts as a major synchronising signal among neurons of the suprachiasmatic nucleus — the brain’s central clock — which places it in chronobiology research alongside its older gastrointestinal and cardiovascular literature.
VIP is a 28-residue peptide with several residues prone to oxidation and deamidation, which makes it less forgiving in storage than the short, robust peptides that surround it on a catalogue. Transit time and temperature exposure matter correspondingly more.
Domestic fulfilment shortens the uncontrolled leg of the journey and gives you a Canadian counterparty when a lot does not match its paperwork. Neither replaces checking the material on arrival, and neither is a quality claim about what is in the vial.
For a 28-residue peptide with oxidation-prone residues, degradation products matter as much as gross purity.
Red Leaf publishes Janoshik reports with a verification key. On a peptide this susceptible to oxidation, a purity figure with no impurity profile behind it is a partial answer.
The 10mg vial arrives as a lyophilized cake. Lyophilization describes how the water was removed and implies nothing about identity or purity.
VIP is more sensitive than most short peptides to oxidation, moisture and repeated handling, and it adsorbs to container surfaces at low concentrations — a real source of error when preparing dilute working solutions. Consider low-binding labware and a carrier protein where the assay allows it. Inspect the cake, connect the vial to its analytical report, and follow validated institutional procedures. Background on diluent choice is in bacteriostatic water uses and handling.
Working out concentration for this vial? Our peptide reconstitution calculator converts vial size and bacteriostatic water volume into mg per mL and U-100 syringe units.
Fulfilment is to qualified Canadian purchasers by domestic express. Red Leaf supplies material and documentation; it does not advise on study design and provides nothing that supports use in humans or animals.
VIP holds no marketing authorization in Canada as a consumer or clinical product and has not been assessed for consumer safety or effectiveness by Health Canada.
Research supply and public medical availability are separate categories. A vial available to a qualified laboratory is not an approved retail medicine, a treatment, or a substitute for professional care. Anyone searching from a personal health motivation should speak with a licensed clinician rather than a research supplier.
| Check | What to confirm |
|---|---|
| Purpose | Authorized laboratory research with an approved study plan |
| Design | In-vitro or in-vivo settled, with the two-minute half-life accounted for |
| Identity | 28-residue VIP, mass near 3.3 kDa, registry number checked against sequence |
| Impurities | Oxidised and deamidated species resolved where relevant |
| Labware | Adsorption accounted for in dilute preparations |
| Verification | Report can be checked against the issuing laboratory |
| Handling | Storage and preparation procedures validated by the receiving institution |
For supplier-selection criteria in the Canadian market, review how to evaluate a Canadian research peptide supplier. For a wider survey of compounds studied in this space, see research peptides worth knowing.
VPAC1 and VPAC2, both class II G protein-coupled receptors in the secretin/glucagon receptor family.
At roughly two minutes in circulation, native VIP cannot sustain systemic exposure. It is a strong in-vitro receptor-pharmacology tool; whole-organism work in this area generally relies on engineered analogues or delivery strategies instead.
No. The sequences are identical across those species, so a report naming any of them describes the same molecule.
VIP acts as a major synchronising signal among neurons of the suprachiasmatic nucleus, the brain’s central circadian pacemaker.
No. Red Leaf Research Labs supplies research material and analytical documentation only.
Research use only. VIP supplied by Red Leaf Research Labs is intended for qualified laboratory research. It is not a medicine, not for human or veterinary use, and not for diagnostic or therapeutic application.
Third-party tested purity
Ultra high synthesis purity
Temperature controlled logistics
Trusted by researchers worldwide
This product is supplied in a lyophilized powder form to preserve its stability, purity, and potency.
For laboratory research purposes only. Not intended for human consumption.

You must be 18 or 19 years of age depending on the age of majority in your province and a licensed research professional
All products are sold in powder (lyophilized) form and require reconstitution with a suitable diluent for research purposes only. No dosing instructions are provided. We adhere to all provincial and federal laws in Canada around Research Only Chemical sales. We are not a pharmacy and/or compounding facility, nor do we promote or provide any advice for human or animal consumption.
By clicking ”I Agree” you confirm that you have read and accepted the Terms and Conditions stated above